BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23644134)

  • 41. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
    Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
    ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
    [No Abstract]   [Full Text] [Related]  

  • 42. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Glucagonoma. A tumor disease with multiple clinical manifestations].
    Andersson K; Wängberg B; Tisell LE; Nilsson O; Fjälling M; Forssell-Aronsson E; Ahrén B; Ahlman H
    Lakartidningen; 1996 Aug; 93(35):2935-9. PubMed ID: 8815353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [2 rare pancreatic tumors as incidental findings. A case report].
    Niebuhr H; Rückert K; Nahrstedt U
    Zentralbl Chir; 1991; 116(23):1341-9. PubMed ID: 1776374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pancreatic glucagonoma. Apropos of a case].
    Mathis P; Diebold MD; Servel R
    Chirurgie; 1987; 113(3):258-61. PubMed ID: 2820663
    [No Abstract]   [Full Text] [Related]  

  • 48. [Malignant pancreatic glucagonoma treated by total radical pancreatectomy. 1st Spanish case report and review of the world literature].
    Martínez Díez M; Castiella Muruzábal T; Aguilella Diago V; Ingelmo Setien A; García Gil A; Garín Chesa P; González González M
    Rev Esp Enferm Apar Dig; 1983 May; 63(5):401-20. PubMed ID: 6308726
    [No Abstract]   [Full Text] [Related]  

  • 49. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [66-year-old patient with necrolytic migratory erythema, weight loss, anemia and diabetes mellitus].
    Michels G; Rasokat H; Nierhoff D; Steffen HM
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1601-2. PubMed ID: 20717864
    [No Abstract]   [Full Text] [Related]  

  • 52. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
    Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
    Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response of glucagonomas to surgical excision and chemotherapy. Report of two cases and review of the literature.
    Reyes-Govea J; Holm A; Aldrete JS
    Am Surg; 1989 Aug; 55(8):523-7. PubMed ID: 2548427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoreduction surgery for metastatic glucagonoma. A clinicopathologic study with special reference to the utility of immunocytochemistry and ultrastructure in diagnosis.
    Rader DL; Martin JK; Scheithauer BW
    Minn Med; 1984 Sep; 67(9):483-5, 516. PubMed ID: 6092886
    [No Abstract]   [Full Text] [Related]  

  • 56. [A clinical analysis of glucagonoma syndrome (four cases reported)].
    Ma DL; Zeng JY; Wang BX; Fang K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):210-3. PubMed ID: 12905724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
    Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
    Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
    El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
    Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagonoma and necrolytic migratory erythema.
    Echenique-Elizondo M; Martínez de Lizarduy I
    Rev Esp Enferm Dig; 2005 Jun; 97(6):455-7. PubMed ID: 16011420
    [No Abstract]   [Full Text] [Related]  

  • 60. [The glucagonoma syndrome].
    Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
    Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.